1 |
Nunan, J. and Small, D. H. : Regulation of APP cleavage by -secretases. FEBS Lett. 483, 6 (2000).
DOI
ScienceOn
|
2 |
Cho, W. J., Min, S. Y., Le, T. N. and Kim, T. S. : Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity. Bioorg. Med. Chem. Lett. 13, 4451 (2003).
DOI
ScienceOn
|
3 |
Wang, R., Sweeney, D., Gandy, S. E. and Sissodia, S. S. : The profile of soluble amyloid protein in cultured cell media. J. Biol. Chem. 271, 31894 (1996).
DOI
ScienceOn
|
4 |
Tung, J. S., Davis, D. L., Anderson, J. P., Walker, D. E., Mamo, S., Jewett, N., Hom, R. K., Sinha, S., Thorsett, E. D. and John, V. : Design of substrate-based inhibitors of human -secretase. J. Med. Chem. 45, 259 (2002).
DOI
ScienceOn
|
5 |
Kinoshita, A., Fukumoto, H., Shah, T., Whelan, C. M., Irizarry, M. C. and Hyman, B. T. : Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J. Cell. Sci. 116, 3339 (2003).
DOI
ScienceOn
|
6 |
Leem, J. Y., Saura, C. A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L. T., Veselits, M. L., Tomita, T., Gasparini, L., Iwatsubo, T., Xu, H., Green, W. N., Koo, E. H. and Thinakaran, G. : A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11, 64 (2002).
DOI
ScienceOn
|
7 |
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I. Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe. D. J. : Mutant presenilins of Alzheimer's disease increase production of 42- residue amyloid -protein in both transfected cells and transgenic mice, Nat. Med. 3, 67 (1997).
DOI
ScienceOn
|
8 |
Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y. Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D. S., Holmes, E., Milman, P., Liang, Y., Zhang, D. M., Xu, D. H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R., Farrer, L. S., Sorbi, S., Bruni, A., Fraser, P. and St. George-Hyslop, P. : Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and processing. Nature 407, 48 (2000).
DOI
ScienceOn
|
9 |
Lee, S. F., Shah, S., Li, H., Yu, C., Han, W. and Yu, G. : Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid- precursor protein and Notch. J. Biol. Chem. 277, 45013 (2002).
DOI
ScienceOn
|
10 |
Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. : PEN-2 is an integral component of the -secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277, 39062 (2002).
DOI
ScienceOn
|
11 |
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. D. : Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098 (1993).
DOI
ScienceOn
|
12 |
Hardy, J. and Selkoe, D. J. : The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353 (2002).
DOI
ScienceOn
|
13 |
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L. and Wong, P. C. : BACE1 is the major -secretase for generation of A peptides by neurons. Nature Neurosci. 4, 233 (2001).
DOI
ScienceOn
|
14 |
Leem, J. Y., et al. : Effect of a quinoline compound from the oriental medicine on the metabolism of -amyloid precursor protein in neuroblastoma cells. (manuscript in preparation).
|
15 |
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L. and Pericak-Vance, M. A. : Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921 (1993).
DOI
|
16 |
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G. and Citron, M. : -Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735 (1999).
DOI
ScienceOn
|
17 |
Selkoe, D. J. : Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, 23 (1999).
DOI
ScienceOn
|
18 |
Morris, J. C. : Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165, 41 (1996).
|
19 |
Jann, M. W. : Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20, 1 (2000).
DOI
ScienceOn
|
20 |
Iqbal, K., Sisodia, S. S. and Winblad, B. : Alzheimer's disease: Advances in etionlogy, pathogenesis and therapeutics. John Wiley & Sons, Ltd. (2001).
|
21 |
Braak, H., Braak, E. and Strothjohann, M. : Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett. 171, 1 (1994).
DOI
ScienceOn
|
22 |
Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K. and Muller-Hill, B. : The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733 (1987).
DOI
ScienceOn
|
23 |
Selkoe, D. J. : The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447 (1998).
DOI
ScienceOn
|
24 |
Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T. and Iwatsubo, T. : Sulindac sulfide is a noncompetitive -secretase inhibitor that preferentially reduces 42 generation. J. Biol. Chem. 278, 18664 (2003).
DOI
ScienceOn
|
25 |
Bertram, L., Lill, C. M. and Tanzi, R. E. : The genetics of Alzheimer disease: back to the future. Neuron. 68, 270 (2010).
DOI
ScienceOn
|
26 |
Sugimoto, H. : Donepezil hydrochloride: a treatment drug for Alzheimer's disease. Chem. Rec. 1, 63 (2001).
DOI
ScienceOn
|
27 |
Zarotsky, V., Sramek, J. J., and Cutler, N. R. : Galantamine hydrobromide: an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60, 446 (2003).
|
28 |
Kulkarni, S. K. and Dhir, A. : Berberine, a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 24, 317 (2010).
DOI
ScienceOn
|
29 |
Jung, H. A., Min, B. S., Yokozawa, T., Lee, J. H., Kim, Y. S. and Choi, J. S. : Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol. Pharm. Bull. 32, 1433 (2009).
DOI
ScienceOn
|
30 |
Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. : Water-soluble (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077 (1996).
DOI
|
31 |
Sambamurti, K., Hardy, J., Refolo L. M. and Lahiri, D. K. : Targeting APP metabolism for the treatment of Alzheimer's disease. Drug Dev. Res. 56, 211 (2002).
DOI
ScienceOn
|
32 |
Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W. and Lee, V. M. : Protein kinase C-dependent -secretase competes with -secretase for cleavage of amyloid- precursor protein in the trans-golgi network. J. Biol. Chem. 275, 2568 (2000).
DOI
ScienceOn
|